Leelamine Exerts Antineoplastic Effects in Association with Modulating Mitogen‑Activated Protein Kinase Signaling Cascade

References

• Kim S-M, Kim C, Bae H, Lee JH, Baek SH, Nam D, Chung W-S, Shim BS, Lee S-G, Kim S-H, et al. 6-Shogaol exerts anti-proliferative and pro-apoptotic effects through the modulation of STAT3 and MAPKs signaling pathways. Mol Carcinog. 2015;54(10):1132–46. doi:10.1002/mc.22184
   PubMed Web of Science ®Google Scholar
• Kostenko S, Dumitriu G, Laegreid KJ, Moens U. Physiological roles of mitogen-activated-protein-kinase-activated p38-regulated/activated protein kinase. World J Biol Chem. 2011;2(5):73–89. doi:10.4331/wjbc.v2.i5.73
   PubMedGoogle Scholar
• Owens DM, Keyse SM. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene. 2007;26(22):3203–13. doi:10.1038/sj.onc.1210412
   PubMed Web of Science ®Google Scholar
• Raman M, Chen W, Cobb MH. Differential regulation and properties of MAPKs. Oncogene. 2007;26(22):3100–12. doi:10.1038/sj.onc.1210392
   PubMed Web of Science ®Google Scholar
• Zhang Y, Dong C. Regulatory mechanisms of mitogen-activated kinase signaling. Cell Mol Life Sci. 2007;64(21):2771–89. doi:10.1007/s00018-007-7012-3
   PubMed Web of Science ®Google Scholar
• Wang H, Segaran C, Chan LY, Aladresi A, Chinnathambi A, Alharbi SA, Sethi G, Tang FR . Gamma radiation-induced disruption of cellular junctions in HUVECs is mediated through affecting MAPK/NF-κB inflammatory pathways. Oxid Med Cell Longev. 2019;2019:1486232. doi:10.1155/2019/1486232
   PubMed Web of Science ®Google Scholar
• Ahn KS, Sethi G, Jain AK, Jaiswal AK, Aggarwal BB. Genetic deletion of NAD(P)H: quinone oxidoreductase 1 abrogates activation of nuclear factor-κB, IκBα Kinase, c-Jun N-terminal Kinase, Akt, p38, and p44/42 mitogen-activated protein kinases and potentiates apoptosis*. J Biol Chem. 2006;281(29):19798–808. doi:10.1074/jbc.M601162200
   PubMed Web of Science ®Google Scholar
• Woo CC, Hsu A, Kumar AP, Sethi G, Tan KH. Thymoquinone inhibits tumor growth and induces apoptosis in a breast cancer xenograft mouse model: the role of p38 MAPK and ROS. PLoS One. 2013;8(10):e75356. doi:10.1371/journal.pone.0075356
   PubMed Web of Science ®Google Scholar
• Dai X, Wang L, Deivasigamni A, Looi CY, Karthikeyan C, Trivedi P, Chinnathambi A, Alharbi SA, Arfuso F, Dharmarajan A, et al. A novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinoma. Oncotarget. 2017;8(8):12831–42. doi:10.18632/oncotarget.14606
   PubMedGoogle Scholar
• Kirtonia A, Sethi G, Garg M. The multifaceted role of reactive oxygen species in tumorigenesis. Cell Mol Life Sci. 2020;77(22):4459–83. doi:10.1007/s00018-020-03536-5
   PubMed Web of Science ®Google Scholar
• Kyriakis JM, Avruch J. Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol Rev. 2012;92(2):689–737. doi:10.1152/physrev.00028.2011
   PubMed Web of Science ®Google Scholar
• Chen L, Jiang K, Chen H, Tang Y, Zhou X, Tan Y, Yuan Y, Xiao Q, Ding K. Deguelin induces apoptosis in colorectal cancer cells by activating the p38 MAPK pathway. Cancer Manag Res. 2019;11:95–105. doi:10.2147/cmar.s169476
   PubMed Web of Science ®Google Scholar
• Chen Y, Wu Q, Song SY, Su WJ. Activation of JNK by TPA promotes apoptosis via PKC pathway in gastric cancer cells. World J Gastroenterol. 2002;8(6):1014–8. doi:10.3748/wjg.v8.i6.1014
   PubMed Web of Science ®Google Scholar
• Wu N, Gu C, Gu H, Hu H, Han Y, Li Q. Metformin induces apoptosis of lung cancer cells through activating JNK/p38 MAPK pathway and GADD153. Neoplasma. 2011;58(6):482–90. doi:10.4149/neo_2011_06_482
   PubMed Web of Science ®Google Scholar
• Kang YH, Lee SJ. The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells. J Cell Physiol. 2008;217(1):23–33. doi:10.1002/jcp.21470
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang X, Zhang J, Li Y, Liu W, Wang Z, Wang Y, Si S. A small molecule, MTBT, prevents cancer cell growth by activating p38 MAPK. Anticancer Drugs. 2014;25(4):423–32. doi:10.1097/cad.0000000000000074
   PubMed Web of Science ®Google Scholar
• Mohan CD, Liew YY, Jung YY, Rangappa S, Preetham H, Chinnathambi A, Alahmadi TA, Alharbi SA, Lin Z-X, Rangappa K, et al. Brucein D modulates MAPK signaling cascade to exert multi-faceted anti-neoplastic actions against breast cancer cells. Biochimie. 2021;182:140–51. doi:10.1016/j.biochi.2021.01.009
   PubMed Web of Science ®Google Scholar
• Mohan CD, Rangappa S, Nayak C, Jadimurthy R, Wang L, Sethi G, Garg M, Rangappa K. Bacteria as a treasure house of secondary metabolites with anticancer potential. Semin Cancer Biol. 2021; doi:10.1016/j.semcancer.2021.05.006
   Web of Science ®Google Scholar
• Uzma F, Mohan C, Hashem A, Konappa N, Rangappa S, Kamath P, Singh B, Mudili V, Gupta V, Siddaiah C, et al. Endophytic fungi—alternative sources of cytotoxic compounds: a review. Front Pharmacol. 2018;9:309. doi: 10.3389/fphar.2018.00309
   PubMed Web of Science ®Google Scholar
• Mohan CD, Hari S, Preetham HD, Rangappa S, Barash U, et al. Targeting heparanase in cancer: inhibition by synthetic, chemically modified, and natural compounds. iScience. 2019;15:360–90. doi:10.1016/j.isci.2019.04.034
   PubMed Web of Science ®Google Scholar
• Tewari D, Nabavi SF, Nabavi SM, Sureda A, Farooqi AA, Atanasov A, Vacca RA, Sethi G, Bishayee A. Targeting activator protein 1 signaling pathway by bioactive natural agents: possible therapeutic strategy for cancer prevention and intervention. Pharmacol Res. 2018;128:366–75. doi:10.1016/j.phrs.2017.09.014
   PubMed Web of Science ®Google Scholar
• Shanmugam MK, Warrier S, Kumar AP, Sethi G, Arfuso F. Potential role of natural compounds as anti-angiogenic agents in cancer. Curr Vasc Pharmacol. 2017;15(6):503–19. doi:10.2174/1570161115666170713094319
   PubMed Web of Science ®Google Scholar
• Kashyap D, Tuli HS, Yerer MB, Sharma A, Sak K, Srivastava S, Pandey A, Garg VK, Sethi G, Bishayee A, et al. Natural product-based nanoformulations for cancer therapy: opportunities and challenges. Semin Cancer Biol. 2021;69:5–23. doi:10.1016/j.semcancer.2019.08.014
   PubMed Web of Science ®Google Scholar
• Sethi G, Shanmugam M, Warrier S, Merarchi M, Arfuso F, Kumar A, Bishayee A. Pro-apoptotic and anti-cancer properties of diosgenin: a comprehensive and critical review. Nutrients. 2018;10(5):645. doi:10.3390/nu10050645
   PubMed Web of Science ®Google Scholar
• Jung YY, Um J-Y, Nasif O, Alharbi SA, Sethi G, et al. Blockage of the JAK/STAT3 signaling pathway in multiple myeloma by leelamine. Phytomedicine. 2021; 87:153574. doi: 10.1016/j.phymed.2021.153574
   PubMed Web of Science ®Google Scholar
• Mohan CD, Kim C, Siveen KS, Manu KA, Rangappa S, Chinnathambi A, Alharbi SA, Rangappa K, Kumar AP, Ahn KS, et al. Crocetin imparts antiproliferative activity via inhibiting STAT3 signaling in hepatocellular carcinoma. IUBMB Life. 2021;73(11):1348–62. doi:10.1002/iub.2555
   PubMed Web of Science ®Google Scholar
• Arora L, Mohan CD, Yang MH, Rangappa S, Deivasigamani A, Kumar AP, Kunnumakkara A, Garg M, Chinnathambi A, Alharbi SA, et al. Tris(dibenzylideneacetone)dipalladium(0) (Tris DBA) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by regulating the STAT3 signaling pathway. Cancers. 2021;13(21):5479. doi:10.3390/cancers13215479
   PubMed Web of Science ®Google Scholar
• Mohan CD, Rangappa S, Preetham HD, Chandra Nayaka S, Gupta VK, et al. Targeting STAT3 signaling pathway in cancer by agents derived from Mother Nature. Semin Cancer Biol. 2020;80:157–82. doi:10.1016/j.semcancer.2020.03.016
   PubMed Web of Science ®Google Scholar
• Gowda R, Madhunapantula SV, Kuzu OF, Sharma A, Robertson GP. Targeting multiple key signaling pathways in melanoma using leelamine. Mol Cancer Ther. 2014;13(7):1679–89. doi:10.1158/1535-7163.MCT-13-0867
   PubMed Web of Science ®Google Scholar
• Kuzu OF, Gowda R, Sharma A, Robertson GP. Leelamine mediates cancer cell death through inhibition of intracellular cholesterol transport. Mol Cancer Ther. 2014;13(7):1690–703. doi:10.1158/1535-7163.mct-13-0868
   PubMed Web of Science ®Google Scholar
• Sehrawat A, Kim S-H, Hahm E-R, Arlotti J, Eiseman J, Shiva S, Rigatti L, Singh S. Cancer-selective death of human breast cancer cells by leelamine is mediated by bax and bak activation. Mol Carcinog. 2017;56(2):337–48. doi:10.1002/mc.22497
   PubMed Web of Science ®Google Scholar
• Singh KB, Ji X, Singh SV. Therapeutic potential of leelamine, a novel inhibitor of androgen receptor and castration-resistant prostate cancer. Mol Cancer Ther. 2018;17(10):2079–90. doi:10.1158/1535-7163.MCT-18-0117
   PubMed Web of Science ®Google Scholar
• Singh KB, Hahm E-R, Pore SK, Singh SV. Leelamine is a novel lipogenesis inhibitor in prostate cancer cells in vitro and in vivo. Mol Cancer Ther. 2019;18(10):1800–10. doi:10.1158/1535-7163.MCT-19-0046
   PubMed Web of Science ®Google Scholar
• Shishodia S, Sethi G, Ahn KS, Aggarwal BB. Guggulsterone inhibits tumor cell proliferation, induces S-phase arrest, and promotes apoptosis through activation of c-Jun N-terminal kinase, suppression of Akt pathway, and downregulation of antiapoptotic gene products. Biochem Pharmacol. 2007;74(1):118–30. doi:10.1016/j.bcp.2007.03.026
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim C, Sethi G, Ahn KS. Brassinin inhibits STAT3 signaling pathway through modulation of PIAS-3 and SOCS-3 expression and sensitizes human lung cancer xenograft in nude mice to paclitaxel. Oncotarget. 2015;6(8):6386–405. doi:10.18632/oncotarget.3443
   PubMed Web of Science ®Google Scholar
• Bharathkumar H, Paricharak S, Dinesh KR, Siveen KS, Fuchs J, Rangappa S, Mohan CD, Mohandas N, Kumar AP, Sethi G, et al. Synthesis, biological evaluation and in silico and in vitro mode-of-action analysis of novel dihydropyrimidones targeting PPAR-γ. RSC Adv. 2014;4(85):45143–6. doi:10.1039/C4RA08713E
   Web of Science ®Google Scholar
• Sulaiman NBS, Mohan CD, Basappa S, Pandey V, Rangappa S, Bharathkumar H, Kumar AP, Lobie P, Rangappa K. An azaspirane derivative suppresses growth and induces apoptosis of ER-positive and ER-negative breast cancer cells through the modulation of JAK2/STAT3 signaling pathway. Int J Oncol. 2016;49(3):1221–9. [PMC]27500741
   PubMed Web of Science ®Google Scholar
• Kim C, Cho S, Kapoor S, Kumar A, Vali S, Abbasi T, Kim S-H, Sethi G, Ahn KS. β-caryophyllene oxide inhibits constitutive and inducible STAT3 signaling pathway through induction of the SHP-1 protein tyrosine phosphatase. Mol Carcinog. 2014;53(10):793–806. doi:10.1002/mc.22035
   PubMed Web of Science ®Google Scholar
• Shanmugam M, Ong T, Kumar AP, Lun C, Ho P, Wong P, Hui K, Sethi G. Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways. Plos One. 2012;7(3):e32476. doi:10.1371/journal.pone.0032476
   PubMed Web of Science ®Google Scholar
• Chua AWL, Hay HS, Rajendran P, Shanmugam M, Li F, Bist P, Koay E, Lim L, Kumar AP, Sethi G, et al. Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-κB activation in breast and pancreatic tumor cells. Biochem Pharmacol. 2010;80(10):1553–62. doi:10.1016/j.bcp.2010.07.045
   PubMed Web of Science ®Google Scholar
• Shanmugam M, Manu K, Ong T, Ramachandran L, Surana R, Bist P, Lim L, Kumar AP, Hui K, Sethi G, et al. Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model. Int J Cancer. 2011;129(7):1552–63. doi:10.1002/ijc.26120
   PubMed Web of Science ®Google Scholar
• Ramachandran L, Manu KA, Shanmugam M, Li F, Siveen KS, Vali S, Kapoor S, Abbasi T, Surana R, Smoot D, et al. Isorhamnetin inhibits proliferation and invasion and induces apoptosis through the modulation of peroxisome proliferator-activated receptor γ activation pathway in gastric cancer. J Biol Chem. 2012;287(45):38028–40. doi:10.1074/jbc.M112.388702
   PubMed Web of Science ®Google Scholar
• Sawhney M, Rohatgi N, Kaur J, Shishodia S, Sethi G, Gupta S, Deo S, Shukla N, Aggarwal B, Ralhan R, et al. Expression of NF-kappaB parallels COX-2 expression in oral precancer and cancer: association with smokeless tobacco. Int J Cancer. 2007;120(12):2545–56. doi:10.1002/ijc.22657
   PubMed Web of Science ®Google Scholar
• Manu K, Shanmugam M, Ramachandran L, Li F, Fong CW, Kumar AP, Tan P, Sethi G. First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway. Clin Cancer Res. 2012;18(8):2220–9. doi:10.1158/1078-0432.ccr-11-2470
   PubMed Web of Science ®Google Scholar
• Baburajeev CP, Dhananjaya Mohan C, Ananda H, Rangappa S, Fuchs JE, et al. Development of novel triazolo-thiadiazoles from heterogeneous “green” catalysis as protein tyrosine phosphatase 1B inhibitors. Sci Rep. 2015;5:14195. doi:10.1038/srep14195
   PubMed Web of Science ®Google Scholar
• Deng S, Shanmugam M, Kumar AP, Yap C, Sethi G, Bishayee A. Targeting autophagy using natural compounds for cancer prevention and therapy. Cancer. 2019;125(8):1228–46. doi:10.1002/cncr.31978
   PubMed Web of Science ®Google Scholar
• Dai X, Zhang J, Arfuso F, Chinnathambi A, Zayed ME, Alharbi SA, Kumar AP, Ahn KS, Sethi G. Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy. Exp Biol Med (Maywood). 2015;240(6):760–73. doi:10.1177/1535370215579167
   PubMed Web of Science ®Google Scholar
• Li F, Shanmugam M, Chen L, Chatterjee S, Basha J, Kumar AP, Kundu T, Sethi G. Garcinol, a polyisoprenylated benzophenone modulates multiple proinflammatory signaling cascades leading to the suppression of growth and survival of head and neck carcinoma. Cancer Prev Res (Phila). 2013;6(8):843–54. doi:10.1158/1940-6207.capr-13-0070
   PubMed Web of Science ®Google Scholar
• Manu K, Shanmugam M, Li F, Chen L, Siveen KS, Ahn KS, Kumar AP, Sethi G. Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products. J Mol Med (Berl). 2014;92(3):267–76. doi:10.1007/s00109-013-1095-0
   PubMed Web of Science ®Google Scholar
• Mishra S, Verma S, Rai V, Awasthee N, Chava S, Hui KM, Kumar AP, Challagundla K, Sethi G, Gupta S, et al. Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases. Cell Mol Life Sci. 2019;76(10):1947–66. doi:10.1007/s00018-019-03053-0
   PubMed Web of Science ®Google Scholar
• Chopra P, Sethi G, Dastidar SG, Ray A. Polo-like kinase inhibitors: an emerging opportunity for cancer therapeutics. Expert Opin Investig Drugs. 2010;19(1):27–43. doi:10.1517/13543780903483191
   PubMed Web of Science ®Google Scholar
• Patel SM, Nagulapalli Venkata KC, Bhattacharyya P, Sethi G, Bishayee A. Potential of neem (Azadirachta indica L.) for prevention and treatment of oncologic diseases. Semin Cancer Biol. 2016;40-41:100–15. doi:10.1016/j.semcancer.2016.03.002
   PubMed Web of Science ®Google Scholar
• Merarchi M, Sethi G, Shanmugam M, Fan L, Arfuso F, Ahn K. Role of natural products in modulating histone deacetylases in cancer. Molecules. 2019;24(6):1047. doi:10.3390/molecules24061047
   PubMed Web of Science ®Google Scholar
• Liu C, Ho PC-L, Wong FC, Sethi G, Wang LZ, Goh BC. Garcinol: Current status of its anti-oxidative, anti-inflammatory and anti-cancer effects. Cancer Lett. 2015;362(1):8–14. doi:10.1016/j.canlet.2015.03.019
   PubMed Web of Science ®Google Scholar
• Manu K, Shanmugam M, Ramachandran L, Li F, Siveen KS, Chinnathambi A, Zayed ME, Alharbi SA, Arfuso F, Kumar AP, et al. Isorhamnetin augments the anti-tumor effect of capecitabine through the negative regulation of NF-κB signaling cascade in gastric cancer. Cancer Lett. 2015;363(1):28–36. doi:10.1016/j.canlet.2015.03.033
   PubMed Web of Science ®Google Scholar
• Rakesh K, Jagadish S, Swaroop T, Mohan C, Ashwini N, Harsha K, Zameer F, Girish K, Rangappa K. Anti-cancer activity of 2,4-disubstituted thiophene derivatives: dual inhibitors of lipoxygenase and cyclooxygenase. Med Chem. 2015;11(5):462–72. doi:10.2174/1573406411666141210141918
   PubMed Web of Science ®Google Scholar
• Ahn KS, Sethi G, Aggarwal BB. Reversal of chemoresistance and enhancement of apoptosis by statins through down-regulation of the NF-kappaB pathway. Biochem Pharmacol. 2008;75(4):907–13. doi:10.1016/j.bcp.2007.10.010
   PubMed Web of Science ®Google Scholar
• Merarchi M, Jung YY, Fan L, Sethi G, Ahn KS. A brief overview of the antitumoral actions of leelamine. Biomedicines. 2019;7(3):53. doi:10.3390/biomedicines7030053
   PubMed Web of Science ®Google Scholar
• Singh KB, Hahm E-R, Singh SV. Leelamine suppresses cMyc expression in prostate cancer cells in vitro and inhibits prostate carcinogenesis in vivo. J Cancer Metastasis Treat. 2021;7:16.
   PubMedGoogle Scholar
• Gowda R, Madhunapantula SV, Sharma A, Kuzu OF, Robertson GP. Nanolipolee-007, a novel nanoparticle-based drug containing leelamine for the treatment of melanoma. Mol Cancer Ther. 2014;13(10):2328–40. doi:10.1158/1535-7163.MCT-14-0357
   PubMed Web of Science ®Google Scholar
• Huang C, Jacobson K, Schaller MD. MAP kinases and cell migration. J Cell Sci. 2004;117(Pt 20):4619–28. doi:10.1242/jcs.01481
   PubMed Web of Science ®Google Scholar
• Saika S, Okada Y, Miyamoto T, Yamanaka O, Ohnishi Y, Ooshima A, Liu C-Y, Weng D, Kao WW-Y. Role of p38 MAP kinase in regulation of cell migration and proliferation in healing corneal epithelium. Invest Ophthalmol Vis Sci. 2004;45(1):100–9. doi:10.1167/iovs.03-0700
   PubMed Web of Science ®Google Scholar
• Mohan CD, Bharathkumar H, Bulusu KC, Pandey V, Rangappa S, et al. Development of a novel azaspirane that targets the janus kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo*. J Biol Chem. 2014;289:34296–307. doi:10.1074/jbc.M114.601104
   PubMed Web of Science ®Google Scholar
• Sebastian A, Pandey V, Mohan CD, Chia YT, Rangappa S, et al. Novel adamantanyl-based thiadiazolyl pyrazoles targeting EGFR in triple-negative breast cancer. ACS Omega. 2016;1:1412–24. doi:10.1021/acsomega.6b00251
   PubMed Web of Science ®Google Scholar
• Mohan CD, Rangappa S, Nayak SC, Sethi G, Rangappa KS. Paradoxical functions of long noncoding RNAs in modulating STAT3 signaling pathway in hepatocellular carcinoma. Biochim Biophys Acta (BBA)-Rev Cancer. 1885;74:2021.
   Google Scholar
• Roopashree R, Mohan CD, Swaroop TR, Jagadish S, Raghava B, et al. Novel synthetic bisbenzimidazole that targets angiogenesis in Ehrlich ascites carcinoma bearing mice. Bioorg Med Chem Lett. 2015;25:2589–93. doi:10.1016/j.bmcl.2015.04.010
   PubMed Web of Science ®Google Scholar
• Pandey V, Wang B, Mohan CD, Raquib AR, Rangappa S, et al. Discovery of a small-molecule inhibitor of specific serine residue BAD phosphorylation. Proc Natl Acad Sci. 2018;115:E10505. doi:10.1073/pnas.1804897115
   PubMed Web of Science ®Google Scholar
• Lee JH, Mohan CD, Basappa S, Rangappa S, Chinnathambi A, Alahmadi TA, Alharbi SA, Kumar AP, Sethi G, Ahn KS, et al. The IκB kinase inhibitor ACHP targets the STAT3 signaling pathway in human non-small cell lung carcinoma cells. Biomolecules. 2019;9(12):875. doi:10.3390/biom9120875
   PubMed Web of Science ®Google Scholar
• Lee JH, Rangappa S, Mohan CD, BasappaSethi G, et al. Brusatol, a Nrf2 inhibitor targets STAT3 signaling cascade in head and neck squamous cell carcinoma. Biomolecules. 2019;9:550.
   PubMed Web of Science ®Google Scholar